JP2020502228A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502228A5
JP2020502228A5 JP2019534154A JP2019534154A JP2020502228A5 JP 2020502228 A5 JP2020502228 A5 JP 2020502228A5 JP 2019534154 A JP2019534154 A JP 2019534154A JP 2019534154 A JP2019534154 A JP 2019534154A JP 2020502228 A5 JP2020502228 A5 JP 2020502228A5
Authority
JP
Japan
Prior art keywords
compound
solvent
formula
reaction mixture
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019534154A
Other languages
English (en)
Japanese (ja)
Other versions
JP7294661B2 (ja
JP2020502228A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/058374 external-priority patent/WO2018116281A1/en
Publication of JP2020502228A publication Critical patent/JP2020502228A/ja
Publication of JP2020502228A5 publication Critical patent/JP2020502228A5/ja
Priority to JP2023016009A priority Critical patent/JP2023052918A/ja
Application granted granted Critical
Publication of JP7294661B2 publication Critical patent/JP7294661B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019534154A 2016-12-23 2017-12-22 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス Active JP7294661B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023016009A JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382648 2016-12-23
EP16382648.0 2016-12-23
PCT/IB2017/058374 WO2018116281A1 (en) 2016-12-23 2017-12-22 Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023016009A Division JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Publications (3)

Publication Number Publication Date
JP2020502228A JP2020502228A (ja) 2020-01-23
JP2020502228A5 true JP2020502228A5 (enExample) 2021-02-12
JP7294661B2 JP7294661B2 (ja) 2023-06-20

Family

ID=57799523

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019534154A Active JP7294661B2 (ja) 2016-12-23 2017-12-22 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス
JP2023016009A Withdrawn JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023016009A Withdrawn JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Country Status (19)

Country Link
US (2) US11124505B2 (enExample)
EP (1) EP3559010B1 (enExample)
JP (2) JP7294661B2 (enExample)
KR (1) KR102609373B1 (enExample)
CN (1) CN110198945B (enExample)
BR (1) BR112019012972B1 (enExample)
CA (1) CA3046744A1 (enExample)
CY (1) CY1125531T1 (enExample)
DK (1) DK3559010T3 (enExample)
ES (1) ES2926580T3 (enExample)
HR (1) HRP20221067T1 (enExample)
HU (1) HUE059604T2 (enExample)
IL (1) IL267557B (enExample)
LT (1) LT3559010T (enExample)
MX (1) MX379709B (enExample)
PL (1) PL3559010T3 (enExample)
PT (1) PT3559010T (enExample)
SI (1) SI3559010T1 (enExample)
WO (1) WO2018116281A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110198945B (zh) 2016-12-23 2023-06-27 米尼奥尔克斯治疗有限公司 用于制备噻唑烷二酮化合物及其盐的方法
MX2020013181A (es) 2018-06-06 2021-02-26 Minoryx Therapeutics S L Metodo para administrar una cantidad terapeuticamente efectiva de 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-th iazolidin-2,4-diona.
HUE071482T2 (hu) 2018-06-06 2025-08-28 Minoryx Therapeutics S L (5-[[4-[2-[5-(1-Hidroxietil)piridin-2-il]etoxi]-fenil]metil]-1,3-tiazolidin-2,4- dion és sói mitokondriális betegségek kezelésében vagy megelõzésében történõ alkalmazásra
MX2020013182A (es) 2018-06-06 2021-02-26 Minoryx Therapeutics S L Uso de 5-[[4-[2-[5-acetilpiridin-2-il]etoxi]bencil]-1,3-tiazolidin a-2,4-diona y sus sales.
JP2026500743A (ja) 2022-12-28 2026-01-08 ミノリックス セラピューティクス エセ.エレ. レリグリタゾンの最適投薬
WO2024231881A2 (en) 2023-05-09 2024-11-14 Minoryx Therapeutics S.L. Polymorphic forms and formulations of leriglitazone

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100249988B1 (ko) * 1991-04-11 2000-04-01 로렌스 티. 마이젠헬더 티아졸리딘디온 유도체, 그의 제조방법 및 용도
US5952509A (en) 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
US6067749A (en) 1996-07-11 2000-05-30 Tasmanian Alkaloids Pty. Ltd. Papaver somniferum strain with high concentration of thebaine and oripavine
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
HUP0304096A2 (hu) 2003-12-19 2005-08-29 Richter Gedeon Vegyészeti Gyár Rt. Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
ATE447414T1 (de) 2005-02-16 2009-11-15 Micromet Ag Verwendung aktivierter polymere zur trennung von protein- und polypeptid-multimeren
EP2072519A4 (en) * 2006-09-28 2009-10-21 Banyu Pharma Co Ltd DIARYLKETIMINDERIVAT
JPWO2008136428A1 (ja) * 2007-04-27 2010-07-29 武田薬品工業株式会社 含窒素5員複素環化合物
KR20150003766A (ko) * 2012-04-26 2015-01-09 브리스톨-마이어스 스큅 컴퍼니 혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 및 이미다조피리다진 유도체
CA2941562C (en) 2013-03-14 2021-09-21 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
NZ725492A (en) 2014-04-02 2023-06-30 Minoryx Therapeutics S L 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
CN110198945B (zh) 2016-12-23 2023-06-27 米尼奥尔克斯治疗有限公司 用于制备噻唑烷二酮化合物及其盐的方法

Similar Documents

Publication Publication Date Title
CN101778852B (zh) 双胺化锌碱
JP3501008B2 (ja) 含硫黄有機珪素化合物の製造方法およびその合成中間体の製造方法
HRP20221067T1 (hr) Postupak priprave 5-[[4-[2-[5-(1-hidroksietil)-2-piridinil]etoksi]fenil]metil]-2,4-tiazolidindiona i njegovih soli
CN107004906B (zh) 含镁电解液
JP3728236B2 (ja) テトラキスフルオロアルキルホウ酸塩およびそれらの導電性塩としての使用
CN101044138A (zh) 吲唑化合物的制备方法
CN108432026A (zh) 电解质组合物、二次电池和二次电池的使用方法
EA008389B1 (ru) Способ получения производных 5-(1,3-оксазол-2-ил)бензойной кислоты
EP3546443B1 (en) Method for producing fluorine-containing dialkyl carbonate compounds
JP2014198688A (ja) 環状ポリスルフィド化合物の製造方法
US11180469B2 (en) Method for preparing sultone derivatives
US20170217988A1 (en) Process for the Synthesis of Everolimus and Intermediates Thereof
KR102688867B1 (ko) 리튬 이미다졸레이트염의 제조방법 및 그를 위한 중간체
KR20130114574A (ko) 하이드록시 말단을 지니는 오가노실리콘 글리콜-기반 전해질
CN1333209A (zh) 有机甲硅烷基烷基多硫化物的制备方法
JP2008303161A (ja) 含フッ素アルコキシアルカンの製造方法
JP5095945B2 (ja) 4−トリフルオロメチルニコチン酸又はその塩の製造方法
JP2009084193A (ja) チアゾリウム塩
JP7011204B2 (ja) フルオロポリエーテル基含有化合物
CN106939012B (zh) 一种奈他地尔中间体的制备方法
JP5529591B2 (ja) 多座β−ケトイミネートの金属錯体の調製方法
US7087755B1 (en) Substituted pyridines
JP2013047217A (ja) イオン液体
IL149063A (en) Process for the preparation of ariltriazolanones and their new intermediates
JP7517244B2 (ja) ヒドロキシアルキルシラン化合物の製造方法